Delivery Order SPE2DB20D2104-SPE2DB26FMBCY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count) under a firm fixed-price contract with a ceiling value of $2,777.65. The award was made on December 2, 2025, with an ultimate completion date of December 3, 2025. This non-set-aside award represents a competitive delivery order fulfilling federal pharmaceutical procurement requirements for military and veteran healthcare systems. AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) under a firm fixed-price contract valued at $2,009.04. The award was made on October 27, 2025, with an ultimate completion date of October 28, 2025. This non-competitive delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs, with performance to occur at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on August 28, 2025, with a ceiling value of $1,252.52 and an ultimate completion date of August 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) under a firm fixed-price contract valued at $2,386.32. This non-set-aside award, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a routine pharmaceutical delivery order executed through AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency (DLA) awarded a competitive delivery order valued at $1,219.47 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units). This firm fixed-price delivery order, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a continuation of AmerisourceBergen's pharmaceutical supply support to the federal government. The award was made without any set-aside designation, indicating it was competitively...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,774.88 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitive award employs firm fixed pricing under a delivery order contract type with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $11,614.48 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price contract involves no set-aside designation and represents a competitive award to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,192.55 for 100 tablets of Premarin 0.625 mg on October 29, 2025, with an ultimate completion date of October 30, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,489.63 to AmerisourceBergen Drug Corp for the supply of Premarin 0.9 mg tablets (100 count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is located in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100-count) under a firm fixed price contract with a ceiling value of $6,555.56. The delivery order, issued on November 20, 2025, with an ultimate completion date of November 21, 2025, represents a pharmaceutical procurement supporting federal medical supply needs. This non-set-aside, competitively awarded contract was performed at AmerisourceBergen Drug Corp's...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMBCYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100 count) under a firm fixed-price contract valued at $2,146.52. The order, issued on October 28, 2025, with an ultimate completion date of October 29, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The SPE2DX vehicle serves as a comprehensive global pharmaceutical support contract enabling the supply of diverse pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/28/25 |